Celso Iglesias García1, Pilar López García2, José Luis Ayuso Mateos3, José Ángel García4, Julio Bobes5. 1. Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Neurociencias del Principado de Asturias (INEUROPA), Universidad de Oviedo, Oviedo, Asturias, España; Hospital Valle del Nalón, Servicio de Salud del Principado de Asturias (ISPA.FIMBA), Langreo, Asturias, España. Electronic address: icelso@yahoo.es. 2. Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Universidad Autónoma de Madrid, Madrid, España; Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, México. 3. Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Universidad Autónoma de Madrid, Madrid, España; Instituto de Investigación Sanitaria del Hospital Universitario La Princesa, Madrid, España. 4. Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, México. 5. Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Neurociencias del Principado de Asturias (INEUROPA), Universidad de Oviedo, Oviedo, Asturias, España.
Abstract
INTRODUCTION: The World Health Organization has developed a new classification of mental disorders in Primary Health Care (PHC), the ICD-11-PHC, in which there are changes in the diagnostic criteria of anxiety and depression disorder. In addition, 2 screening instruments have been developed for the detection of anxious and depressive symptoms according to the criteria of the new classification. OBJECTIVES: To evaluate the capacity of the Spanish version of the 2 brief scales Dep5 and Anx5 to identify cases of depression and anxiety in PHC in Spain. METHOD: A cross-sectional study conducted by 37 PHC physicians who selected 284 patients with suspected emotional distress. This sample was administered the screening scales (Anx5 and Dep5) and a diagnostic instrument (Clinical Interview Schedule-Revised) contemplating the new ICD-11 criteria as used as gold standard. RESULTS: The Anx5, using a cut-off point of 3, showed a sensitivity of 0.75 and specificity of 0.53. Using a cut-off point of 4, the Dep5 showed a sensitivity of 0.48 and a specificity of 0.8. The 2 scales together, with a cut-off point of 3 for each, classified correctly 73,57% as cases or non-cases. The diagnosis most frequently observed was anxious depression. CONCLUSIONS: The screening scales for anxious and depressive symptoms (Anx5 and Dep5) are simple and easy-to-use instruments for assessing anxious and depressive symptoms in PHC. The reliability and validity data of each of the scales separately are limited but the figures improve when they are used together.
INTRODUCTION: The World Health Organization has developed a new classification of mental disorders in Primary Health Care (PHC), the ICD-11-PHC, in which there are changes in the diagnostic criteria of anxiety and depression disorder. In addition, 2 screening instruments have been developed for the detection of anxious and depressive symptoms according to the criteria of the new classification. OBJECTIVES: To evaluate the capacity of the Spanish version of the 2 brief scales Dep5 and Anx5 to identify cases of depression and anxiety in PHC in Spain. METHOD: A cross-sectional study conducted by 37 PHC physicians who selected 284 patients with suspected emotional distress. This sample was administered the screening scales (Anx5 and Dep5) and a diagnostic instrument (Clinical Interview Schedule-Revised) contemplating the new ICD-11 criteria as used as gold standard. RESULTS: The Anx5, using a cut-off point of 3, showed a sensitivity of 0.75 and specificity of 0.53. Using a cut-off point of 4, the Dep5 showed a sensitivity of 0.48 and a specificity of 0.8. The 2 scales together, with a cut-off point of 3 for each, classified correctly 73,57% as cases or non-cases. The diagnosis most frequently observed was anxious depression. CONCLUSIONS: The screening scales for anxious and depressive symptoms (Anx5 and Dep5) are simple and easy-to-use instruments for assessing anxious and depressive symptoms in PHC. The reliability and validity data of each of the scales separately are limited but the figures improve when they are used together.
Authors: Sarah Sánchez-Cueva; Yurena Alonso-Esteban; Patricio Sánchez-Cueva; Boris Birmaher; Francisco Alcantud-Marín Journal: Front Psychiatry Date: 2021-02-11 Impact factor: 4.157